Volume 9, number 2

Utilization of Bacteria as Virulence Agents for Urinary Tract Infectionin Egyptian Patients

Mohamed E. Zayed1, Suliman A Alharbi2, Inas M Masoud2 and Reda A Ammar3

1Department of Botany and Microbiology, Faculty of Science, King Saud University, Riyadh 11541, Saudi Arabia.

2Department of Applied Medical Chemistry , Medical Research Institute, Alexandria University, Egypt.

3Department of Chemistry ,Faculty of Science, King Saud University, Riyadh 11541, Saudi Arabia.

DOI : http://dx.doi.org/http://dx.doi.org/10.13005/bbra/1029

ABSTRACT:

This study involved an examination ofbacteriuria according to the results of quantitative cultures in overall 300 urine samples collected from patients admitted at El-Hussein University Hospital. The infection rate of both E. coli and Klebsiella pneumoniae were found to be 26.92 and 11.54%; respectively. As the glucose and albumin concentration increased, the number of all infectious organisms was greatly increased. Similarly when creatinine concentration elevated up to 3.5 g/l, the infectious organisms (Enterobacterfaecalis, Streptococcus sp. (B) group, Proteus mirabilis, P. aeruginosa, Enterobactersp. and Citrobacterfreundii) were significantly increased. The effect of sodium chloride (NaCl), calcium oxalate (CaC2O4), magnesium chloride (MgCl2) and uric acid (C5H4N4O3) concentrations were fluctuated according to the concentration used and the type of each infectious organism. Noracin was effective against all tested organisms. Acinetobactersp. recorded 50% resistance to ampicillin while it was sensitive to all other tested antibiotics.

KEYWORDS: Bacteriuria; Creatinine; Antibiotics.

Copy the following to cite this article:

Zayed M. E, Alharbi S. A, Masoud I. M, Ammar R. A. Utilization of Bacteria as Virulence Agents for Urinary Tract Infectionin Egyptian Patients. Biosci Biotech Res Asia 2012;9(2)

Copy the following to cite this URL:

Zayed M. E, Alharbi S. A, Masoud I. M, Ammar R. A. Utilization of Bacteria as Virulence Agents for Urinary Tract Infectionin Egyptian Patients. Biosci Biotech Res Asia 2012;9(2). Available from: https://www.biotech-asia.org/?p=9913

[ HTML Full Text]

Back to TOC